3
Total investments
1
Early stage
1
Mid stage
0
Late stage
10y
Years active
Portfolio
2 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jul 2018
Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify insulin delivery, reducing the burden on both patients and the overall healthcare system.
CapBios first product is the patent-pending SteadiSet infusion set for insulin pump therapy. Its SteadiFlow technology features a kink-proof, super-soft cannula with multi-port delivery designed for reliable and comfortable insulin delivery. Our user-friendly insertion device makes it easy.
The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA. This ongoing academic-industry collaboration is focused on improving the comfort, reliability and predictability of insulin infusion therapy. Together, we aim to achieve more consistent and reliable insulin absorption, which will enable people with diabetes to achieve improved blood glucose control.
Experience ยท 5 entries
All (5)
Investments (3)
Founder (1)
Board (2)
2018
Board Observer
Jul 2018
Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes management. We aim to dramatically simplify insulin delivery, reducing the burden on both patients and the overall healthcare system.
CapBios first product is the patent-pending SteadiSet infusion set for insulin pump therapy. Its SteadiFlow technology features a kink-proof, super-soft cannula with multi-port delivery designed for reliable and comfortable insulin delivery. Our user-friendly insertion device makes it easy.
The company is based in Irvine, CA and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA. This ongoing academic-industry collaboration is focused on improving the comfort, reliability and predictability of insulin infusion therapy. Together, we aim to achieve more consistent and reliable insulin absorption, which will enable people with diabetes to achieve improved blood glucose control.
Board Member
May 2018
A DTC men's self-care brand - starting with the face.
Backed by science and Manufactured in the USA.
2017
S
StaffUp.com
Founder
Jun 2017
2016
S
Sugar Pine Ridge Capital
Investor
Dec 2016
2010
Investment activity
2016โ2018 ยท 3 investments
Recent (last 2 years)Earlier
